Literature DB >> 14555799

Variation in the distribution of trace elements in hepatoma.

Hiraku Tashiro1, Toshihiro Kawamoto, Toshiteru Okubo, Osamu Koide.   

Abstract

There are many reports of reduction of zinc level and rise of copper level in serum of patients with liver disease. However, there are a few reports that compare the trace elements in tumor tissues and nontumor tissues of the liver with hepatoma. We studied trace element distribution in tumor tissues and nontumor tissues of liver with hepatoma and compared them with data from normal liver tissues. Zinc (Zn), copper (Cu), selenium (Se), cadmium (Cd), mercury (Hg), and iron (Fe) were chosen as the trace elements to be observed. We observed falls of Zn, Cd, and Hg levels in tumor tissues and the rise of Cu level as a result of this investigation. Zn, Cd, and Hg levels in tumor tissues were significantly lower than those in nontumor tissues and Zn, Cd, and Hg levels in nontumor tissues were significantly lower than in normal liver tissues. This tendency was clearer for Cd and Hg than for Zn. Although the distribution of Cu was not significant, a distribution contrary to that of Zn was shown. These findings indicate that the distribution of Zn, Cd, and Hg can serve as supportive evidence that could be useful as a tumor marker. Selenium showed almost the same accumulation tendency among tumor tissues, nontumor tissues, and normal livers. Although correlation was observed among most metals in the normal liver, there was almost no correlation in tumor tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555799     DOI: 10.1385/BTER:95:1:49

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  14 in total

Review 1.  Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Expert Rev Anticancer Ther       Date:  2012-01       Impact factor: 4.512

Review 2.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

Review 3.  The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

4.  ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer.

Authors:  Renty B Franklin; Bernard A Levy; Jing Zou; Nader Hanna; Mohamed Mokhtar Desouki; Omar Bagasra; Leslie A Johnson; Leslie C Costello
Journal:  J Gastrointest Cancer       Date:  2012-06

5.  A possible predictive marker of progression for hepatocellular carcinoma.

Authors:  Michele DI Stasio; Maria Grazia Volpe; Giovanni Colonna; Melissa Nazzaro; Miriam Polimeno; Stefania Scala; Giuseppe Castello; Susan Costantini
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

Review 6.  The important role of the apoptotic effects of zinc in the development of cancers.

Authors:  Renty B Franklin; Leslie C Costello
Journal:  J Cell Biochem       Date:  2009-04-01       Impact factor: 4.429

7.  Meta-analysis of the correlation between selenium and incidence of hepatocellular carcinoma.

Authors:  Ziwei Zhang; Mingyu Bi; Qi Liu; Jie Yang; Shiwen Xu
Journal:  Oncotarget       Date:  2016-11-22

8.  High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters.

Authors:  Tomoka Takatani-Nakase; Chihiro Matsui; Sachie Maeda; Satomi Kawahara; Koichi Takahashi
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Serum and tissue zinc in epithelial malignancies: a meta-analysis.

Authors:  Jaromir Gumulec; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Ivo Provaznik; Rene Kizek
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

10.  The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression.

Authors:  Zhen Yang; Sun Yang; Bobbye J Misner; Feng Liu-Smith; Frank L Meyskens
Journal:  Int J Oncol       Date:  2014-08-08       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.